Cargando…

Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal

The fate of intraperitoneally injected or implanted male rat bone marrow-derived stromal cells inside female sibling host animals was traced using Y-chromosome-sensitive PCR. When injected intraperitoneally, Y-chromosome-positive cells were found in all studied organs: heart muscle, lung, thymus, li...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Timothy, Stark, Christoffer, Holmbom, Johanna, Rosling, Ari, Kuusilehto, Asko, Tirri, Teemu, Penttinen, Risto, Ekholm, Erika
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042670/
https://www.ncbi.nlm.nih.gov/pubmed/21350643
http://dx.doi.org/10.4061/2010/345806
_version_ 1782198559402098688
author Wilson, Timothy
Stark, Christoffer
Holmbom, Johanna
Rosling, Ari
Kuusilehto, Asko
Tirri, Teemu
Penttinen, Risto
Ekholm, Erika
author_facet Wilson, Timothy
Stark, Christoffer
Holmbom, Johanna
Rosling, Ari
Kuusilehto, Asko
Tirri, Teemu
Penttinen, Risto
Ekholm, Erika
author_sort Wilson, Timothy
collection PubMed
description The fate of intraperitoneally injected or implanted male rat bone marrow-derived stromal cells inside female sibling host animals was traced using Y-chromosome-sensitive PCR. When injected intraperitoneally, Y-chromosome-positive cells were found in all studied organs: heart muscle, lung, thymus, liver, spleen, kidney, skin, and femoral bone marrow with a few exceptions regardless of whether they had gone through osteogenic differentiation or not. In the implant experiments, expanded donor cells were seeded on poly(lactide-co-glycolide) scaffolds and grown under three different conditions (no additives, in osteogenic media for one or two weeks) prior to implantation into corticomedullar femoral defects. Although the impact of osteogenic in vitro cell differentiation on cell migration was more obvious in the implantation experiments than in the intraperitoneal experiments, the donor cells stay alive when injected intraperitoneally or grown in an implant and migrate inside the host. However, when the implants contained bioactive glass, no signs of Y-chromosomal DNA were observed in all studied organs including the implants indicating that the cells had been eliminated.
format Text
id pubmed-3042670
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-30426702011-02-24 Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal Wilson, Timothy Stark, Christoffer Holmbom, Johanna Rosling, Ari Kuusilehto, Asko Tirri, Teemu Penttinen, Risto Ekholm, Erika J Tissue Eng Research Article The fate of intraperitoneally injected or implanted male rat bone marrow-derived stromal cells inside female sibling host animals was traced using Y-chromosome-sensitive PCR. When injected intraperitoneally, Y-chromosome-positive cells were found in all studied organs: heart muscle, lung, thymus, liver, spleen, kidney, skin, and femoral bone marrow with a few exceptions regardless of whether they had gone through osteogenic differentiation or not. In the implant experiments, expanded donor cells were seeded on poly(lactide-co-glycolide) scaffolds and grown under three different conditions (no additives, in osteogenic media for one or two weeks) prior to implantation into corticomedullar femoral defects. Although the impact of osteogenic in vitro cell differentiation on cell migration was more obvious in the implantation experiments than in the intraperitoneal experiments, the donor cells stay alive when injected intraperitoneally or grown in an implant and migrate inside the host. However, when the implants contained bioactive glass, no signs of Y-chromosomal DNA were observed in all studied organs including the implants indicating that the cells had been eliminated. SAGE-Hindawi Access to Research 2010-08-01 /pmc/articles/PMC3042670/ /pubmed/21350643 http://dx.doi.org/10.4061/2010/345806 Text en Copyright © 2010 Timothy Wilson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wilson, Timothy
Stark, Christoffer
Holmbom, Johanna
Rosling, Ari
Kuusilehto, Asko
Tirri, Teemu
Penttinen, Risto
Ekholm, Erika
Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal
title Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal
title_full Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal
title_fullStr Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal
title_full_unstemmed Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal
title_short Fate of Bone Marrow-Derived Stromal Cells after Intraperitoneal Infusion or Implantation into Femoral Bone Defects in the Host Animal
title_sort fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042670/
https://www.ncbi.nlm.nih.gov/pubmed/21350643
http://dx.doi.org/10.4061/2010/345806
work_keys_str_mv AT wilsontimothy fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal
AT starkchristoffer fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal
AT holmbomjohanna fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal
AT roslingari fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal
AT kuusilehtoasko fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal
AT tirriteemu fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal
AT penttinenristo fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal
AT ekholmerika fateofbonemarrowderivedstromalcellsafterintraperitonealinfusionorimplantationintofemoralbonedefectsinthehostanimal